Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families

Journal of the American Academy of Dermatology

Volumn 65, Issue 2, 2011, Pages 289-296

  Van Der Rhee, Jasper I ^a   De Snoo, Femke A ^a   Vasen, Hans F A ^b   Mooi, Wolter J ^c   Putter, Hein ^a   Gruis, Nelleke A ^a   Kukutsch, Nicole A ^a   Bergman, Wilma ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Netherlands Foundation for the Detection of Hereditary Tumors   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CDKN2A; dysplastic nevus syndrome; genes; melanoma; prevention and control

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CASE CONTROL STUDY; FAMILY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCREENING; TUMOR DIAGNOSIS;

AGE DISTRIBUTION; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; FEMALE; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MASS SCREENING; MELANOMA; NEOPLASM STAGING; ODDS RATIO; PEDIGREE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79960384627     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.06.067     Document Type: Article

References (22)

1. C.G. Ang, J.W. Kelly, L. Fritschi, and J.P. Dowling Characteristics of familial and non-familial melanoma in Australia Melanoma Res 8 1998 459 464 (Pubitemid 28530799)
2. C.J. Hussussian, J.P. Struewing, A.M. Goldstein, P.A. Higgins, D.S. Ally, and M.D. Sheahan Germline p16 mutations in familial melanoma Nat Genet 8 1994 15 21 (Pubitemid 24274055)
3. A. Kamb, N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, and S.V. Tavtigian A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
4. D.T. Bishop, F. Demenais, A.M. Goldstein, W. Bergman, J.N. Bishop, and B. Bressac-de Paillerets Geographical variation in the penetrance of CDKN2A mutations for melanoma J Natl Cancer Inst 94 2002 894 903 (Pubitemid 34778088)
5. E. de Vries, S. Houterman, M.L. Janssen-Heijnen, T. Nijsten, S.A. van de Schans, and A.M. Eggermont Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands Ann Oncol 18 2007 1110 1116 (Pubitemid 47050504)
6. A.M. Goldstein, M. Chan, M. Harland, N.K. Hayward, F. Demenais, and D.T. Bishop Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents J Med Genet 44 2007 99 106
7. N.A. Gruis, P.A. van der Velden, L.A. Sandkuijl, D.E. Prins, J. Weaver-Feldhaus, and A. Kamb Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds Nat Genet 10 1995 351 353
8. H.F. Vasen, W. Bergman, A. van Haeringen, E. Scheffer, and E.A. van Slooten The familial dysplastic nevus syndrome: natural history and the impact of screening on prognosis; a study of nine families in The Netherlands Eur J Cancer Clin Oncol 25 1989 337 341 (Pubitemid 19054838)
9. W. Liu, J.P. Dowling, W.K. Murray, G.A. McArthur, J.F. Thompson, and R. Wolfe Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas Arch Dermatol 142 2006 1551 1558 (Pubitemid 44969210)
10. S.E. Koch, and J.R. Lange Amelanotic melanoma: the great masquerader J Am Acad Dermatol 42 2000 731 734 (Pubitemid 30252874)
11. F.A. de Snoo, D.T. Bishop, W. Bergman, I. van Leeuwen, C. van der Drift, and F.A. van Nieuwpoort Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families Clin Cancer Res 14 2008 7151 7157
12. H.F. Vasen, N.A. Gruis, R.R. Frants, P.A. Der Velden, E.T. Hille, and W. Bergman Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 87 2000 809 811 (Pubitemid 30660559)
13. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
14. S. Højsgaard, U. Halekoh, and J. Yan The R package geepack for generalized estimating equations J Stat Software 15 2005 1 11
15. G.D. Masri, W.H. Clark Jr., D. Guerry, A. Halpern, C.J. Thompson, and D.E. Elder Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease J Am Acad Dermatol 22 1990 1042 1048 (Pubitemid 20186126)
16. W.P. Carey Jr., C.J. Thompson, M. Synnestvedt, D. Guerry, A. Halpern, and D. Schultz Dysplastic nevi as a melanoma risk factor in patients with familial melanoma Cancer 74 1994 3118 3125 (Pubitemid 24375068)
17. J. Hansson, M. Bergenmar, P.A. Hofer, G. Lundell, E. Mansson-Brahme, and U. Ringborg Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program J Clin Oncol 25 2007 2819 2824 (Pubitemid 47123192)
18. H. Kittler, R. Weitzdorfer, H. Pehamberger, K. Wolff, and M. Binder Compliance with follow-up and prognosis among patients with thin melanomas Eur J Cancer 37 2001 1504 1509 (Pubitemid 32744680)
19. G. Argenziano, I. Mordente, G. Ferrara, A. Sgambato, P. Annese, and I. Zalaudek Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols Br J Dermatol 159 2008 331 336 (Pubitemid 352009843)
20. R. Schiffner, J. Schiffner-Rohe, M. Landthaler, and W. Stolz Long-term dermoscopic follow-up of melanocytic nevi: clinical outcome and patient compliance Br J Dermatol 149 2003 79 86 (Pubitemid 36966514)
21. W.H. Clark Jr., D.E. Elder, D. Guerry, M.N. Epstein, M.H. Greene, and M. Van Horn A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165 (Pubitemid 15128121)
22. M.A. Richard, J.J. Grob, M.F. Avril, M. Delaunay, X. Thirion, and P. Wolkenstein Melanoma and tumor thickness-challenges of early diagnosis Arch Dermatol 135 1999 269 274 (Pubitemid 29159208)